Tega Therapeutics, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Tega Therapeutics, Inc.
Quantité totale PI 15
Rang # Quantité totale PI 103 068
Note d'activité PI 1,8/5.0    9
Rang # Activité PI 101 937

Brevets

Marques

5 0
3 0
7 0
0
 
Dernier brevet 2024 - Heparin from modified mst cells ...
Premier brevet 2016 - Cellular glycosaminoglycan compo...

Derniers inventions, produits et services

2023 Invention Von willebrand disease animal models. Disclosed herein are methods of generating an animal model ...
2022 Invention Cellular glycosaminoglycan compositions and methods of making and using. Disclosed herein are su...
Invention Heparin from modified mst cells and methods of making and using. Provided herein are methods of ...
Invention Heparin from modified mst cells and methods of making and using. Provided herein are methods of p...
2021 Invention Protein s antibodies, methods of making and uses thereof. Provided here are antibodies that bind ...
2020 Invention Heparin and heparan sulfate from modified mst cells and methods of making and using. Abstract: P...
Invention Heparin and heparan sulfate from modified mst cells and methods of making and using. Provided her...
2017 Invention In vitro heparin and heparan sulfate compositions and methods of making and using. Disclosed her...
Invention In vitro heparin and heparan sulfate compositions and methods of making and using. Disclosed here...
2016 Invention Cellular glycosaminoglycan compositions and methods of making and using. Disclosed herein are sub...